Monthly Archives: November 2026

Export Tax Refund and Document Consistency for Peptide Exporters (2026)

Export Tax Refund and Document Consistency for Peptide Exporters (2026) An export tax refund is claimed against a paper trail, and the claim fails when the trail disagrees with itself. This guide sets out how the refund chain is built, where documents most often diverge, and how to keep a claim defensible when the tax […]

Order Change and Expedite Handling for Peptides (2026)

Order Change and Expedite Handling for Peptides (2026) Most supply failures are not made at the factory; they are made when an order changes after the material has been committed. This guide sets out how to handle quantity changes, date pulls and specification amendments without breaking either the schedule or the quality record. Key Research […]

Freedom to Operate and Patent Clearance for Peptide Products (2026)

Freedom to Operate and Patent Clearance for Peptide Products (2026) Freedom to operate is a negative opinion, not a certificate: it says that no third-party patent found in a defined search appears to cover a defined product in a defined market. Getting that opinion right depends on searching the patent families that actually matter, reading […]

Dangerous Goods Classification and IATA Packing for Peptide Shipments (2026)

Dangerous Goods Classification and IATA Packing for Peptide Shipments (2026) Peptides are usually not dangerous goods, but the shipments that carry them often are: dry ice is a regulated substance, some solvents and preservatives are flammable, and biological materials have their own classification. This guide explains how to decide whether a consignment is regulated, which […]

Demurrage and Detention Cost Control for Peptide Shipments (2026)

Demurrage and Detention Cost Control for Peptide Shipments (2026) Demurrage and detention are the charges that accrue when a container sits in a terminal or stays out of it longer than the free period allows, and they are one of the few logistics costs entirely avoidable through planning. This guide sets out when the clock […]

Business Continuity and Supply Interruption Planning for Peptide Suppliers (2026)

Peptide supply chains are short, concentrated and easy to interrupt: one synthesis site, one purification suite, one qualified testing laboratory, one cold-chain lane. This guide explains how to identify the interruptions that would actually stop shipments, how to size buffers against them, and what a credible response looks like when the event happens. Key Research […]

Transfer Pricing and Intercompany Pricing for Peptide Groups (2026)

A peptide group that buys from one entity, sells through another and holds intellectual property in a third has three tax authorities asking the same question: is the price between them the price an unrelated party would have paid? This guide covers the methods that answer it, why the customs value is a different number, […]

Utility and Energy Management for Peptide Manufacturing (2026)

The utilities behind a peptide facility, purified water, clean steam, compressed air, chilled water and HVAC, are usually invisible until one of them fails, at which point production stops and batches are rejected. This guide covers what to meter, how to build an energy baseline that supports decisions, and how to manage the single points […]